Showing results (151-160 of 251) with videos related to
Sort By:
Pageof 26
Journal of Gastrointestinal Cancer|September 1, 2021
Extra-Colonic Malignancy in Inflammatory Bowel Disease: a Paucity of Recommendations with Weak EvidenceSimcha Weissman, Muhammad Aziz, Matthew R Baniqued, et al.AJR. American Journal of Roentgenology|June 16, 2016
Localizing Acute Lower Gastrointestinal Hemorrhage: CT Angiography Versus Tagged RBC ScintigraphyJoseph D Feuerstein, Gyanprakash Ketwaroo, Sumeet K Tewani, et al.Journal of Crohn'S & Colitis|January 29, 2019
Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel DiseaseKonstantinos Papamichael, Anna Juncadella, Danny Wong, et al.Gastroenterology Report|August 2, 2016
An open-access endoscopy screen correctly and safely identifies patients for conscious sedationDarshan Kothari, Joseph D Feuerstein, Laureen Moss, et al.Inflammatory Bowel Diseases|June 10, 2023
Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients: Systematic Review and Meta-AnalysisVikas Taneja, Rajsavi S Anand, Mohammed El-Dallal, et al.International Journal of Colorectal Disease|March 18, 2021
Impact of inflammatory bowel disease on hospital outcomes in acute ischemic stroke: a nationwide cohort studySara Ghoneim, Simcha Weissman, Linda Wang, et al.Inflammatory Bowel Diseases|July 2, 2024
Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous VedolizumabRachel Porth, Tina Deyhim, Samantha Zullow, et al.The American Journal of Gastroenterology|February 3, 2023
Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG GuidelineNeil Sengupta, Joseph D Feuerstein, Vipul Jairath, et al.Digestive Diseases and Sciences|December 9, 2025
Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated with Less Treatment Failure in Patients with Inflammatory Bowel Disease Treated with AdalimumabAjay Gade, Alessandra Saraga, Tina Deyhim, et al.Inflammatory Bowel Diseases|September 26, 2024
Proactive Therapeutic Drug Monitoring of Ustekinumab Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel DiseaseRachel Porth, Tina Deyhim, Grace Geeganage, et al.Pageof 26